Increased apoptotic activity is associated with hospital mortality and disruption in lipid homeostasis in acute-on-chronic liver failure.

Mark McPhail, Evangelos Triantafyllou, Debbie Shawcross, Charalambos G. Antoniades, Mattew R. Lewis, Elizabeth Want, Vishal C. Patel, Yasmin Pasha, (Robin) Daniel Abeles, William Bernal, Elaine Holmes, Julia Wendon, Simon D. Taylor-Robinson

    Research output: Contribution to journalMeeting abstractpeer-review

    Abstract

    Background Apoptosis is an important mechanism of hepatocyte cell death in acetaminophen acute liver failure (AALF), sepsis and by lipoapoptosis in non-alcoholic steatohepatitis (NASH). In AALF and NASH peripheral blood levels of apoptotic and necrotic markers (total and caspase cleaved cytokeratin-18) reflect underlying severity of disease. Acute-on-chronic liver failure (ACLF) is associated with reduction in high and low density lipoprotein (HDL,LDL) and phosphocholine (PC) concentrations but whether this reflects increased apoptotic activity is not known. Methods Fifty nine patients with cirrhosis (33 ACLF(12 died; 21 survived); 26 compensated (CLD)) and 7 healthy controls (HC) were studied. Median age was 55(23-65) years with 41 male, 18 female. The aetiology of cirrhosis was alcohol(32), viral(6) , NASH (7) , autoimmune(10) and other(4). Peripheral blood plasma was tested on admission for levels of total and caspase-cleaved cytokeratin 18 (M30,M65). Global metabolic and lipid of plasma was performed by 1H nuclear magnetic resonance spectroscopy (NMR) and reverse phase ultra performance liquid chromatography mass spectrometry (UPLCMS). Multivariate analysis was performed by orthogonal projection to least squares (OPLS) and univariate analysis by Spearman rank correlation and Kruskall-Wallis test. Results Levels of M30 were elevated in both CLD and ACLF compared with HC (p<0.01 HC v CLD; p<0001 HC v ACLF). Similarly the plasma levels of M65 were also highest in ACLF patients compared with CLD and HC (p<0.0001 ACLF v HC; p<0.01 CLD v HC). M30/M65 ratios were lowest in DC compared to other groups (p<0.0001 HC v CLD; p<0.001 HC v ACLF). M30 and M65 were correlated with MELD score (M30 v MELD r=0.40, p=0.002; M65 v MELD r=0.39, p=0.004). On OPLS modelling M65 (but not M30) levels correlated negatively with the LDL (p(corr)=-0.87,p<0.001) and PC(p(corr)=-0.79,p<0.001) resonances on 1H NMR. Of the identified lipids on UPLCMS LPC(16:0) at 520 m/z was negatively correlated with M30 (r=-0.30,p=0.010) and M65 (r=-0.39,p=0.002) levels and also predicted hospital survival (AUROC 0.76 (95%CI 0.66-0.84),p<0.001). M65 levels performed less well at outcome prediction (AUROC 0.66 (95%CI 0.54-0.76), p=0.02). M30 and M30/M65 ratio were not independently associated with outcome. Conclusion ACLF is associated with an increase in levels of both total and caspase cleaved cytokeratin-18 which correlates with increasing MELD score and reduced LDL and LPC levels in peripheral blood. This suggests that hepatocyte death mediated by lipo-apoptotic mechanisms is an important component in the progression of severe disease and poor outcome in ACLF.
    Original languageEnglish
    Article number1324
    Pages (from-to)851A-852A
    Number of pages2
    JournalHepatology
    Volume58
    Publication statusPublished - Oct 2013
    Event64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases - Washington, United Kingdom
    Duration: 1 Nov 20135 Nov 2013

    Fingerprint

    Dive into the research topics of 'Increased apoptotic activity is associated with hospital mortality and disruption in lipid homeostasis in acute-on-chronic liver failure.'. Together they form a unique fingerprint.

    Cite this